Celgene Corporation Form 483 Details
Form 483Source: FDA record for this establishmentFDA publishes inspections or enforcement actions for this establishment, listed further down this page, but we have not matched this particular Form 483 to a document or an inspection date FDA has released. It stays out of the default view for that reason.
To check this against FDA, open FDA's record for this establishment on FDA's Data Dashboard, which lists this inspection under FEI 3004991673.
Celgene Corporation
Summit, New Jersey, United States
Issue DateMarch 19, 2010
FEI Number3004991673
CountryUnited States
Status
No Warning LetterProduct Type
Drugs